Physician profile
Daniel D Feldmann
NPI 1558338632
$6,036.23
in general payments reported to CMS, 2019-2025
10 companies · $2,284 in 2025
The $2,284 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.23 · 2020: $500 · 2021: $299 · 2022: $318 · 2023: $1,977 · 2024: $573 · 2025: $2,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,926 · Food and Beverage: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,925.69 |
| Food and Beverage | $1,909.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,765.89 | 2022-2025 | |
| Novus Surgical Consultants | $767.52 | 2023-2025 | |
| Stryker Corporation | $709.84 | 2019-2023 | Mako, Triathlon, Tritanium |
| Novus Surgical Solutions LLC | $545.38 | 2020-2021 | |
| Smith+Nephew, INC. | $71.52 | 2019 | |
| Vericel Corporation | $55.08 | 2024 | Maci |
| Medacta USA, INC. | $50.56 | 2025 | Gmk Sphere |
| Ermi LLC | $36.20 | 2024 | |
| Globus Medical, INC. | $17.79 | 2025 | Actify 3d |
| Becton, Dickinson and Company | $16.45 | 2025 | Channel Drain |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Feldmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.